Guided Therapeutics, Inc. (GTHP)
USD 0.08
(-0.12%)
USD 0.08
(-0.12%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -3.12 Million USD | -3.91% |
| 2022 | -3.68 Million USD | -83.13% |
| 2021 | -918.99 Thousand USD | -126.89% |
| 2020 | 777 Thousand USD | 10.02% |
| 2019 | -488 Thousand USD | 40.83% |
| 2018 | 2.8 Million USD | 49.24% |
| 2017 | -9.37 Million USD | -14.27% |
| 2016 | -852 Thousand USD | 59.39% |
| 2015 | -4.53 Million USD | 28.17% |
| 2014 | -8.42 Million USD | -41.07% |
| 2013 | -6.7 Million USD | -56.76% |
| 2012 | -3.92 Million USD | 41.68% |
| 2011 | -6.53 Million USD | -315.97% |
| 2010 | -1.61 Million USD | 12.79% |
| 2009 | -2.22 Million USD | 39.44% |
| 2008 | -2.91 Million USD | 9.81% |
| 2007 | 2.44 Million USD | 26.08% |
| 2006 | -4.59 Million USD | -5.57% |
| 2005 | -1.81 Million USD | 36.14% |
| 2004 | -8.93 Million USD | 32.58% |
| 2003 | -5.91 Million USD | -44.46% |
| 2002 | -7.5 Million USD | -1.47% |
| 2001 | -6.87 Million USD | -9.98% |
| 2000 | -6.24 Million USD | 0.56% |
| 1999 | -6.3 Million USD | 19.23% |
| 1998 | -7 Million USD | -36.84% |
| 1997 | -5.5 Million USD | -103.57% |
| 1996 | -2.7 Million USD | -382.76% |
| 1995 | -580 Thousand USD | 58.87% |
| 1994 | -1.41 Million USD | -15.57% |
| 1993 | -1.22 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -631 Thousand USD | -93.65% |
| 2024 Q1 | -336 Thousand USD | -7.9% |
| 2023 Q3 | -602 Thousand USD | 59.41% |
| 2023 FY | - USD | -3.91% |
| 2023 Q1 | -823 Thousand USD | 10.15% |
| 2023 Q4 | -462.95 Thousand USD | 23.1% |
| 2023 Q2 | -1.48 Million USD | -80.19% |
| 2022 FY | - USD | -83.13% |
| 2022 Q3 | -1.2 Million USD | -71.75% |
| 2022 Q2 | -701 Thousand USD | -64.94% |
| 2022 Q1 | -425 Thousand USD | -30.37% |
| 2022 Q4 | -916 Thousand USD | 23.92% |
| 2021 Q3 | -100 Thousand USD | 81.27% |
| 2021 Q1 | -823 Thousand USD | -1110.29% |
| 2021 Q2 | -534 Thousand USD | 35.12% |
| 2021 Q4 | -326 Thousand USD | -226.0% |
| 2021 FY | - USD | -126.89% |
| 2020 Q1 | -241 Thousand USD | -48.77% |
| 2020 Q4 | -68 Thousand USD | 55.56% |
| 2020 Q2 | -319 Thousand USD | -32.37% |
| 2020 Q3 | -153 Thousand USD | 52.04% |
| 2020 FY | - USD | 10.02% |
| 2019 Q1 | -248 Thousand USD | 42.46% |
| 2019 Q3 | -162 Thousand USD | 45.08% |
| 2019 Q4 | -162 Thousand USD | 0.0% |
| 2019 Q2 | -295 Thousand USD | -18.95% |
| 2019 FY | - USD | 40.83% |
| 2018 Q1 | -356 Thousand USD | 40.17% |
| 2018 Q4 | -431 Thousand USD | -89.87% |
| 2018 FY | - USD | 49.24% |
| 2018 Q2 | -471 Thousand USD | -32.3% |
| 2018 Q3 | -227 Thousand USD | 51.8% |
| 2017 Q4 | -595 Thousand USD | 54.89% |
| 2017 FY | - USD | -14.27% |
| 2017 Q1 | -475 Thousand USD | 50.93% |
| 2017 Q2 | -497 Thousand USD | -4.63% |
| 2017 Q3 | -1.31 Million USD | -165.39% |
| 2016 FY | - USD | 59.39% |
| 2016 Q1 | -1.07 Million USD | 30.31% |
| 2016 Q3 | -495 Thousand USD | -1355.88% |
| 2016 Q4 | -968 Thousand USD | -95.56% |
| 2016 Q2 | -34 Thousand USD | 96.84% |
| 2015 Q1 | -999 Thousand USD | 53.51% |
| 2015 FY | - USD | 28.17% |
| 2015 Q2 | -1.38 Million USD | -38.94% |
| 2015 Q3 | -1.53 Million USD | -10.59% |
| 2015 Q4 | -1.54 Million USD | -0.59% |
| 2014 FY | - USD | -41.07% |
| 2014 Q2 | -1.84 Million USD | 6.01% |
| 2014 Q1 | -1.96 Million USD | -59.12% |
| 2014 Q3 | -2.35 Million USD | -27.77% |
| 2014 Q4 | -2.14 Million USD | 8.79% |
| 2013 FY | - USD | -56.76% |
| 2013 Q4 | -1.23 Million USD | 19.04% |
| 2013 Q3 | -1.52 Million USD | 6.33% |
| 2013 Q2 | -1.62 Million USD | 7.77% |
| 2013 Q1 | -1.76 Million USD | -65.7% |
| 2012 Q1 | -921 Thousand USD | 67.86% |
| 2012 Q4 | -1.06 Million USD | -21.6% |
| 2012 Q3 | -875 Thousand USD | 17.45% |
| 2012 Q2 | -1.06 Million USD | -15.09% |
| 2012 FY | - USD | 41.68% |
| 2011 Q4 | -2.86 Million USD | -8.6% |
| 2011 Q2 | -481 Thousand USD | 34.65% |
| 2011 FY | - USD | -315.97% |
| 2011 Q3 | -2.63 Million USD | -448.65% |
| 2011 Q1 | -736 Thousand USD | -90.18% |
| 2010 Q3 | -603 Thousand USD | -13.77% |
| 2010 Q1 | -192 Thousand USD | 62.5% |
| 2010 FY | - USD | 12.79% |
| 2010 Q2 | -530 Thousand USD | -176.04% |
| 2010 Q4 | -387 Thousand USD | 35.82% |
| 2009 Q4 | -512 Thousand USD | -134.86% |
| 2009 FY | - USD | 39.44% |
| 2009 Q2 | -522 Thousand USD | -5120.0% |
| 2009 Q3 | -218 Thousand USD | 58.24% |
| 2009 Q1 | -10 Thousand USD | 98.05% |
| 2008 Q2 | -735 Thousand USD | -24.58% |
| 2008 Q1 | -590 Thousand USD | 29.26% |
| 2008 FY | - USD | 9.81% |
| 2008 Q4 | -512 Thousand USD | 52.42% |
| 2008 Q3 | -1.07 Million USD | -46.39% |
| 2007 FY | - USD | 26.08% |
| 2007 Q4 | -834 Thousand USD | 7.85% |
| 2007 Q3 | -905 Thousand USD | 18.83% |
| 2007 Q2 | -1.11 Million USD | -49.26% |
| 2007 Q1 | -747 Thousand USD | 31.28% |
| 2006 Q3 | -1.1 Million USD | 18.03% |
| 2006 Q4 | -1.08 Million USD | 1.98% |
| 2006 Q2 | -1.35 Million USD | -29.97% |
| 2006 FY | - USD | -5.57% |
| 2006 Q1 | -1.04 Million USD | 15.57% |
| 2005 FY | - USD | 36.14% |
| 2005 Q1 | -1.17 Million USD | 72.47% |
| 2005 Q2 | -922 Thousand USD | 21.26% |
| 2005 Q3 | -1.03 Million USD | -12.15% |
| 2005 Q4 | -1.23 Million USD | -19.25% |
| 2004 FY | - USD | 32.58% |
| 2004 Q1 | -1.46 Million USD | 66.86% |
| 2004 Q2 | -1.6 Million USD | -9.71% |
| 2004 Q3 | -1.6 Million USD | -0.19% |
| 2004 Q4 | -4.25 Million USD | -164.55% |
| 2003 Q1 | -1.07 Million USD | -74.01% |
| 2003 FY | - USD | -44.46% |
| 2003 Q4 | -1.29 Million USD | -162.49% |
| 2003 Q3 | -1.68 Million USD | 7.12% |
| 2003 Q2 | -1.86 Million USD | 15.73% |
| 2002 Q3 | -984 Thousand USD | 69.62% |
| 2002 FY | - USD | -1.47% |
| 2002 Q2 | -3.06 Million USD | -33.87% |
| 2002 Q1 | -2.28 Million USD | -28.13% |
| 2002 Q4 | -1.23 Million USD | -33.08% |
| 2001 FY | - USD | -9.98% |
| 2001 Q3 | -1.54 Million USD | -17.17% |
| 2001 Q2 | -1.31 Million USD | 41.54% |
| 2001 Q1 | -2.25 Million USD | -2023.58% |
| 2001 Q4 | -1.76 Million USD | -15.5% |
| 2000 Q1 | -1.65 Million USD | -39.75% |
| 2000 FY | - USD | 0.56% |
| 2000 Q4 | -106 Thousand USD | 95.51% |
| 2000 Q3 | -2.35 Million USD | -11.12% |
| 2000 Q2 | -2.12 Million USD | -26.6% |
| 1999 Q1 | -1.79 Million USD | -12.5% |
| 1999 Q3 | -900 Thousand USD | 62.5% |
| 1999 FY | - USD | 19.23% |
| 1999 Q4 | -1.2 Million USD | -33.33% |
| 1999 Q2 | -2.39 Million USD | -33.33% |
| 1998 FY | - USD | -36.84% |
| 1998 Q4 | -1.5 Million USD | 36.0% |
| 1998 Q3 | -1.8 Million USD | -8.7% |
| 1998 Q2 | -2.2 Million USD | 0.0% |
| 1998 Q1 | -2 Million USD | -43.75% |
| 1997 Q1 | -1.3 Million USD | -47.73% |
| 1997 FY | - USD | -103.57% |
| 1997 Q2 | -1.2 Million USD | 7.69% |
| 1997 Q3 | -1.3 Million USD | -25.0% |
| 1997 Q4 | -1.7 Million USD | -6.67% |
| 1996 FY | - USD | -382.76% |
| 1996 Q4 | -880 Thousand USD | -1.15% |
| 1996 Q3 | -870 Thousand USD | -19.18% |
| 1996 Q2 | -730 Thousand USD | -12.31% |
| 1996 Q1 | -650 Thousand USD | 0.0% |
| 1995 FY | - USD | 58.87% |
| 1994 FY | - USD | -15.57% |
| 1993 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| CVR Medical Corp. | - USD | Infinity% |
| BioElectronics Corporation | -274.29 Thousand USD | -1039.67% |
| IR-Med Inc. | -4.89 Million USD | 36.1% |
| Polarean Imaging plc | -11.19 Million USD | 72.077% |
| Medical Supply International USA, Inc. | 456.06 Thousand USD | 785.436% |
| Avitar, Inc. | -1.66 Million USD | -87.432% |
| AVITA Medical, Inc. | -39.56 Million USD | 92.1% |
| Manhattan Scientifics, Inc. | -1.16 Million USD | -168.557% |
| Össur hf. | 137.38 Million USD | 102.275% |
| Zecotek Photonics Inc. | -3.44 Million USD | 9.186% |
| QHSLab, Inc. | -91.29 Thousand USD | -3324.14% |
| Wellstar International, Inc. | -1.35 Million USD | -130.443% |
| Össur hf. | 137.38 Million USD | 102.275% |
| Bionovate Technologies Corp | - USD | Infinity% |
| EKF Diagnostics Holdings plc | 9.77 Million USD | 131.983% |
| Escalon Medical Corp. | -58.46 Thousand USD | -5247.155% |
| Aurora Spine Corporation | -454.37 Thousand USD | -587.973% |
| BrainsWay Ltd. | -2.31 Million USD | -35.266% |
| Lattice Biologics Ltd. | - USD | Infinity% |
| NewCardio, Inc. | -9.37 Million USD | 66.671% |
| Hamilton Thorne Ltd. | 5.52 Million USD | 156.614% |
| Vivos Inc. | -2.79 Million USD | -11.917% |
| MicroPort Scientific Corporation | -347.57 Million USD | 99.101% |
| Kelyniam Global, Inc. | -197.69 Thousand USD | -1481.256% |
| REMSleep Holdings, Inc. | -1.66 Million USD | -87.348% |
| CYduct Diagnostics, Inc. | -378.9 Thousand USD | -725.007% |
| Nanomix Corporation | -8.13 Million USD | 61.596% |
| Theraclion SA | -2.05 Million USD | -52.429% |
| Lifeline Biotechnologies, Inc. | - USD | Infinity% |
| Wellness Center USA, Inc. | -707.03 Thousand USD | -342.131% |
| Positron Corporation | -1.45 Million USD | -115.267% |
| Rafina Innovations Inc. | - USD | Infinity% |
| Electromedical Technologies, Inc. | -1.72 Million USD | -81.545% |
| Lombard Medical, Inc. | -28.06 Million USD | 88.863% |
| ALR Technologies Inc. | -6.4 Million USD | 51.159% |
| Stratec SE | 39.91 Million USD | 107.832% |
| Vycor Medical, Inc. | 100.94 Thousand USD | 3196.797% |
| Heart Tronics, Inc. | -14.85 Million USD | 78.959% |
| Nu-Med Plus, Inc. | -118.25 Thousand USD | -2543.351% |
| Perimeter Medical Imaging AI, Inc. | -13.27 Million USD | 76.455% |
| SANUWAVE Health, Inc. | -9.15 Million USD | 65.844% |
| VMS Rehab Systems, Inc. | -68.55 USD | -4560075.055% |
| Ingen Technologies, Inc. | -8639.00 USD | -36084.744% |
| Odyssey Group International, Inc. | -2.13 Million USD | -46.206% |
| United American Healthcare Corporation | -59 Thousand USD | -5198.305% |
| ECGI Holdings, Inc. | -2.99 Million USD | -4.533% |
| Capital Group Holdings, Inc. | -629.18 Thousand USD | -396.835% |
| ADM Tronics Unlimited, Inc. | -514.02 Thousand USD | -508.142% |
| Urologix, Inc. | -6.34 Million USD | 50.725% |
| Rapid Therapeutic Science Laboratories, Inc. | -1.23 Million USD | -152.227% |
| Nexeon MedSystems Inc. | -765.96 Thousand USD | -308.112% |
| SS Innovations International, Inc. | -20.37 Million USD | 84.658% |
| Qualis Innovations, Inc. | -222.81 Thousand USD | -1302.939% |
| Smith & Nephew plc | 1 Billion USD | 100.312% |
| NIOX Group Plc | 11.07 Million USD | 128.225% |
| Fuse Medical, Inc. | 1.83 Million USD | 270.325% |
| Broncus Holding Corporation | -25.19 Million USD | 87.595% |
| Brain Scientific Inc. | -7.93 Million USD | 60.599% |
| Pressure BioSciences, Inc. | -9.39 Million USD | 66.712% |
| Health Logic Interactive Inc. | -18.4 Thousand USD | -16889.13% |